Final Report of Safety and Efficacy From a Novel Conditioning Regimen, Individualized Once-Daily Intravenous Busulfan with Bortezomib, in Relapsed Multiple Myeloma Patients Undergoing a Second Autologous Hematopoietic Stem Cell Transplantation.

被引：0

作者：

Stadtmauer, Edward A. ^{[1
]}

Ratanatharathorn, Voravit ^{[2
]}

Yeh, Rosa F. ^{[3
]}

Freytes, Cesar O. ^{[4
]}

Toro, Juan J. ^{[5
]}

Akpek, Gorgun ^{[6
]}

Sahovic, Entezam A. ^{[7
]}

Tricot, Guido J. ^{[8
]}

Shaughnessy, Paul J. ^{[9
]}

White, Darrell J. ^{[10
]}

Rodriguez, Tulio E. ^{[11
]}

Solomon, Scott R. ^{[12
]}

Yu, Louie H. ^{[3
]}

Patil, Shiva ^{[13
]}

Sun, Yiping ^{[13
]}

Armstrong, Elizabeth ^{[13
]}

Smith, Angela ^{[13
]}

Elekes, Agnes ^{[13
]}

Kato, Kazunobu ^{[13
]}

Reece, Donna ^{[14
]}

机构：

[1] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[2] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA

[3] Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA 98104 USA

[4] S Vet Hlth Care Syst, BMT, San Antonio, TX USA

[5] Univ Texas Hlth Sci Ctr San Antonio, S Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA

[6] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA

[7] Western Penn Canc Inst, Cell Transplantat Program, Pittsburgh, PA USA

[8] Univ Utah, Sch Med, Div Hematol, BMT & Myeloma Program, Salt Lake City, UT USA

[9] Texas Transplant Inst, San Antonio, TX USA

[10] Queen Elizabeth 2 Hlth Sci Ctr, Div Hematol, Halifax, NS, Canada

[11] Loyola Univ, Med Ctr, Cardinal Bernardin Canc Ctr, Maywood, IL 60153 USA

[12] Northside Hosp, Blood & Marrow Transplant Program, Atlanta, GA USA

[13] Otsuka Pharmaceut Dev & Commercializat Inc, Princeton, NJ USA

[14] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada

来源：

BLOOD | 2012年 / 120卷 / 21期

关键词：

D O I：

10.1182/blood.V120.21.3080.3080

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3080

引用

页数：2